diphtheria

diphtheria
Name	Diphtheria
Field	Infectious disease
Causes	Corynebacterium diphtheriae (toxin-producing strains)
Prevention	vaccination, public health measures

diphtheria Diphtheria is an acute infectious disease caused by toxin-producing strains of Corynebacterium diphtheriae that primarily affects the upper respiratory tract and skin. Historically associated with high morbidity and mortality during the 19th and early 20th centuries, major reductions followed the introduction of the Diphtheria vaccine and coordinated campaigns by organizations such as the World Health Organization and United Nations Children's Fund. Outbreaks have influenced public health policy in contexts like the interwar public health reforms and post-conflict settings such as 1990s Russia.

Signs and symptoms

Patients commonly present with sore throat, low-grade fever, and malaise, progressing to an adherent pseudomembrane on the tonsils, pharynx, or nasal mucosa described in accounts from the Florence Nightingale era and documented in clinical texts used at Johns Hopkins Hospital. Severe cases may show cervical lymphadenopathy producing "bull neck" deformity, airway obstruction requiring interventions developed at institutions like Guy's Hospital and Massachusetts General Hospital. Systemic absorption of exotoxin can cause myocarditis, arrhythmias, and neuropathies historically managed in intensive care units such as those pioneered at Mayo Clinic and Cleveland Clinic.

Cause and pathophysiology

The disease is caused by toxigenic strains of Corynebacterium diphtheriae, which acquired the tox gene via lysogenic conversion by beta bacteriophage related to findings first interpreted during work by Frederick Loeffler and contemporaries linked to Robert Koch's bacteriology era. The diphtheria toxin inhibits protein synthesis by ADP-ribosylation of elongation factor-2, a mechanism elucidated in studies at Pasteur Institute and corroborated by labs at Harvard Medical School and University of Cambridge. Pathogenicity involves epithelial colonization, pseudomembrane formation, and systemic toxin dissemination with molecular insights contributed by researchers at National Institutes of Health and Max Planck Society affiliates.

Diagnosis

Clinical diagnosis relies on identification of pseudomembranes and compatible symptoms as taught in curricula at Oxford University and University of Pennsylvania School of Medicine. Laboratory confirmation includes culture on selective media and demonstration of toxigenicity via Elek test or PCR assays developed at centers like Centers for Disease Control and Prevention and molecular laboratories at Karolinska Institute. Imaging such as neck radiography or laryngoscopy, techniques standardized at Royal College of Surgeons training programs, assists in assessing airway compromise. Surveillance case definitions used by World Health Organization and national public health agencies guide reporting.

Prevention

Prevention centers on immunization with diphtheria toxoid-containing vaccines integrated into schedules promoted by World Health Organization, UNICEF, and national programs like those of United States CDC and Public Health England. Routine childhood schedules and booster campaigns modeled after initiatives in Sweden and Japan maintain population immunity, while outbreak control has employed ring vaccination strategies referenced in responses by Médecins Sans Frontières and Red Cross. Public health measures drawing on lessons from 1918 influenza pandemic preparedness include surveillance, contact tracing, and provision of antitoxin in resource-limited settings coordinated with Gavi, the Vaccine Alliance.

Treatment

Acute management includes prompt administration of diphtheria antitoxin to neutralize circulating toxin, an approach refined since early 20th-century production at institutions such as the Institut Pasteur and Eli Lilly and Company facilities. Antibiotics—typically erythromycin or penicillin—are used to eradicate organisms, protocols often implemented in hospitals like Charité – Universitätsmedizin Berlin and Mount Sinai Hospital. Severe airway obstruction may require tracheostomy or intubation techniques pioneered in surgical units at St Bartholomew's Hospital and Royal London Hospital. Cardiac and neurologic complications necessitate supportive care in intensive care units modeled after Guy's Hospital and John Radcliffe Hospital practice.

Epidemiology

Diphtheria incidence declined markedly in countries with sustained immunization programs such as United States, United Kingdom, Germany, and Australia, paralleling successes of vaccination campaigns led by World Health Organization and national ministries like France's ministry. Resurgence has occurred in areas of disrupted health systems, documented in outbreaks in Russia in the 1990s, among displaced populations in Sierra Leone and Afghanistan, and localized clusters reported by Pan American Health Organization. Surveillance data collection and vaccination coverage targets are monitored by agencies including European Centre for Disease Prevention and Control and African Union health initiatives to prevent re-emergence.

Category:Diseases